Sanofi could easily save $2B by cutting useless US reps and managers

Especially in diabetes. That insanely overstaffed division need to be slashed in half! Also, cut oncology and the hospital teams. There are just too many fucking reps in this company.

 

You should die.

 

you should be working

 

here here OP a toast to you health! spot on and good show!

 

90% of the slugs could be fired and sales would go up. these so called 'sales" reps offer little and do nothing, shit has more respect.

 

The sad part of it is... if you did cut say another 1000 plus reps right now, Lantus and Plavix would still sell itself and as you stated you'd save a ton of money. This company could easily go to one rep per product per territory, office and hospital responsibility and do fine. The reps would actually be able to carve out a decent week of work, esp if the territories got larger. I dont know if its 90%, but 50% and you would not miss a beat.

 

So true.......

 

If you really want to revert to the old days, give say 2 reps per territory, CV and Diabetes products, that would be 4 if you counted Apidra. Make them call on the specialists and internal Med and hospitals. Even with shrinking access, you'd still have enough offices to call on, get a few lunches etc. Thats how they did it I was told back in the day. Forget this stupid you are one division I am another. You could slash at least 1000 plus more jobs, pay higher bonus to those remaining and weigh the portfolio accordingly. Say 50 percent Lantus, 25 for Apidra, 15 for Multaq and for Plavix, then add that 10 percent back to Multaq when Plavix is done.

 

Waaaaaay too logical for Sanofi to ever figure that out and implement. Way, way, way too logical. Great idea.

 

The only thing making Lantus grow right now are continuous price increases. Go look at the market share--it's been going backwards for 2 years now. We need 1000 more reps, not 1000 less promoting Lantus.

 

you won't likely be selling Multaq soon

 

A thousand more reps for a 12 year old drug? Yeah, that's really smart. I can see why you're successful in sales.

 

I think poster number 8 is on to something, combine the CV and diabetes portfolio, but it would never happen with this management. It would only be short term anyway because Plavix is over come next May and who know with Multaq. But that idea makes perfect sense. Thus it will never fly because at SA logic is never used.